IL112125A - Quinazolinone-containing pharmaceutical compositions - Google Patents

Quinazolinone-containing pharmaceutical compositions

Info

Publication number
IL112125A
IL112125A IL112125A IL11212594A IL112125A IL 112125 A IL112125 A IL 112125A IL 112125 A IL112125 A IL 112125A IL 11212594 A IL11212594 A IL 11212594A IL 112125 A IL112125 A IL 112125A
Authority
IL
Israel
Prior art keywords
cells
halofuginone
mesangial
vol
cell proliferation
Prior art date
Application number
IL112125A
Other languages
English (en)
Other versions
IL112125A0 (en
Inventor
Arnon Nagler
Shimon Slavin
Israel Vlodavsky
Mark Pines
Original Assignee
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service
Priority to IL112125A priority Critical patent/IL112125A/en
Publication of IL112125A0 publication Critical patent/IL112125A0/xx
Priority to PCT/US1995/016932 priority patent/WO1996019224A1/en
Priority to DE69530510T priority patent/DE69530510T2/de
Priority to CNB951969048A priority patent/CN1149995C/zh
Priority to AT95944408T priority patent/ATE238055T1/de
Priority to CA002207097A priority patent/CA2207097C/en
Priority to AU46465/96A priority patent/AU693652B2/en
Priority to JP52003596A priority patent/JP3808505B2/ja
Priority to US08/860,946 priority patent/US5998422A/en
Priority to EP95944408A priority patent/EP0794780B1/en
Publication of IL112125A publication Critical patent/IL112125A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL112125A 1994-12-12 1994-12-22 Quinazolinone-containing pharmaceutical compositions IL112125A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL112125A IL112125A (en) 1994-12-22 1994-12-22 Quinazolinone-containing pharmaceutical compositions
EP95944408A EP0794780B1 (en) 1994-12-22 1995-12-21 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
AT95944408T ATE238055T1 (de) 1994-12-22 1995-12-21 Chinazolinon enthaltende arzneimittel und verfahren zu deren verwendung
DE69530510T DE69530510T2 (de) 1994-12-22 1995-12-21 Chinazolinon enthaltende arzneimittel und verfahren zu deren verwendung
CNB951969048A CN1149995C (zh) 1994-12-22 1995-12-21 喹唑啉酮类化合物在制药中的用途
PCT/US1995/016932 WO1996019224A1 (en) 1994-12-22 1995-12-21 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
CA002207097A CA2207097C (en) 1994-12-22 1995-12-21 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
AU46465/96A AU693652B2 (en) 1994-12-22 1995-12-21 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
JP52003596A JP3808505B2 (ja) 1994-12-22 1995-12-21 キナゾリノンを含有する医薬組成物およびそれの利用方法
US08/860,946 US5998422A (en) 1994-12-12 1995-12-21 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL112125A IL112125A (en) 1994-12-22 1994-12-22 Quinazolinone-containing pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL112125A0 IL112125A0 (en) 1995-03-15
IL112125A true IL112125A (en) 1998-02-08

Family

ID=11066921

Family Applications (1)

Application Number Title Priority Date Filing Date
IL112125A IL112125A (en) 1994-12-12 1994-12-22 Quinazolinone-containing pharmaceutical compositions

Country Status (9)

Country Link
EP (1) EP0794780B1 (ja)
JP (1) JP3808505B2 (ja)
CN (1) CN1149995C (ja)
AT (1) ATE238055T1 (ja)
AU (1) AU693652B2 (ja)
CA (1) CA2207097C (ja)
DE (1) DE69530510T2 (ja)
IL (1) IL112125A (ja)
WO (1) WO1996019224A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
US6440445B1 (en) 1996-09-30 2002-08-27 Brigham & Women's Hospital Methods and compounds for treatment of abnormal uterine bleeding
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
EP2173724B1 (en) 2007-06-22 2012-12-05 ArQule, Inc. Quinazolinone compounds and methods of use thereof
CN114469956B (zh) * 2022-01-29 2023-07-18 中国科学技术大学 常山酮在治疗和预防动脉粥样硬化性疾病的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Also Published As

Publication number Publication date
JP3808505B2 (ja) 2006-08-16
CA2207097C (en) 2002-05-28
DE69530510D1 (de) 2003-05-28
CN1176601A (zh) 1998-03-18
DE69530510T2 (de) 2004-02-19
EP0794780A1 (en) 1997-09-17
AU4646596A (en) 1996-07-10
CA2207097A1 (en) 1996-06-27
AU693652B2 (en) 1998-07-02
JPH10511939A (ja) 1998-11-17
CN1149995C (zh) 2004-05-19
WO1996019224A1 (en) 1996-06-27
IL112125A0 (en) 1995-03-15
ATE238055T1 (de) 2003-05-15
EP0794780B1 (en) 2003-04-23
EP0794780A4 (en) 1997-11-12

Similar Documents

Publication Publication Date Title
CA2280850C (en) Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
US5449678A (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
CN102612564B (zh) 新的抗衰老试剂及其鉴别方法
US6759432B2 (en) Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
EP0787000B1 (en) Quinazolinone pharmaceuticals and use thereof
EP0794780B1 (en) Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
WO1996006616A9 (en) Quinazolinone pharmaceuticals and use thereof
US5998422A (en) Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
DE69633673T2 (de) Verwendung von Halofuginon zur Herstellung eines Medikaments zur Vorbeugung von Neovaskularisation und zur Behandlung bösartiger Tumoren
US6211188B1 (en) Treatment of skin disorders
US6090814A (en) Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
US5684007A (en) Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
KR100540537B1 (ko) 간경변의 치료방법

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees